Scott Jeffers
Direttore Tecnico/Scientifico/R&S presso GENSIGHT BIOLOGICS S.A.
Posizioni attive di Scott Jeffers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Direttore Tecnico/Scientifico/R&S | 01/04/2022 | - |
Storia della carriera di Scott Jeffers
Precedenti posizioni note di Scott Jeffers
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formazione di Scott Jeffers
| Purdue University | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Aziende private | 2 |
|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Scott Jeffers
- Esperienza
